Orexo receives US patent for its nasal epinephrine powder product OX640
Orexo AB, a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs, has announced that the United States Patent and Trademark Office ( …